# OnCo record nct04711135 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04711135/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04711135", "NCT04711135" ;
  schema:name "Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs"@en ;
  schema:alternateName "NETTER-P"@en ;
  schema:description "A phase 2 trial of Lutetium-177 dotatate in pheochromocytoma and paraganglioma, run by Advanced Accelerator Applications, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04711135/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04711135> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2022-08-31" ;
  onco:cancers <https://onco.cc/cancers/pheochromocytoma-paraganglioma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:drugs <https://onco.cc/drugs/lutathera/> ;
  onco:companies <https://onco.cc/companies/novartis/> .